Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

Bone microarchitecture

Outcome Time Frame:

24 months

Safety Issue:

No

Authority:

Australia: Human Research Ethics Committee

Study ID:

MG2009_01

NCT ID:

NCT01006395

Start Date:

January 2011

Completion Date:

March 2015

Related Keywords:

• Prostate Cancer
• Prostate Cancer
• Androgen deprivation
• Bone Health
• Insulin resistance
• Men with nonmetastatic prostate cancer receiving androgen deprivation
• Prostatic Neoplasms